PDE-4 Inhibitors Market Research Report
On Oct 29, the latest report "Global PDE-4 Inhibitors Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031" from Global Info Research provides a detailed and comprehensive analysis of the global PDE-4 Inhibitors market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2025.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2961824/pde-4-inhibitors
According to our (Global Info Research) latest study, the global PDE-4 Inhibitors market size was valued at US$ 5292 million in 2024 and is forecast to a readjusted size of USD 7092 million by 2031 with a CAGR of 4.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
PDE-4 inhibitors are primarily used in the treatment of inflammatory and immune-mediated diseases, such as asthma, chronic obstructive pulmonary disease (COPD), psoriasis, and rheumatoid arthritis. Their development and production rely heavily on high-purity active pharmaceutical ingredients (APIs), such as apremilast and roflumilast, with upstream raw materials mainly supplied by fine chemical manufacturers and specialized API producers from Europe, the US, and India. The manufacturing process also requires excipients such as lactose, microcrystalline cellulose, hydroxypropyl methylcellulose, and magnesium stearate to ensure drug stability and bioavailability.
Downstream customers are concentrated among pharmaceutical companies, hospitals, specialty clinics, and retail pharmacies, spanning from prescription-driven markets in developed countries to public healthcare systems in emerging economies. Since PDE-4 inhibitors are often prescribed for long-term use to maintain therapeutic benefits, demand is characterized by large patient populations and extended treatment cycles, placing high requirements on manufacturers’ supply reliability. Moreover, with the ongoing expansion of therapeutic indications, several companies are actively promoting PDE-4 inhibitors in dermatology and rheumatology, providing new drivers for diversified market growth.
In 2024, the global average price of PDE-4 inhibitors is approximately USD 25.4 per unit (with "unit" referring to one oral tablet or one injectable), with total sales reaching about 202 million units.
This report is a detailed and comprehensive analysis for global PDE-4 Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
PDE-4 Inhibitors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Apremilast、 Crisaborole、 Roflumilast、 Others
Market segment by Application: Hospital、 Clinic、 Others
Major players covered: Amgen、 Pfizer、 AstraZeneca、 Anacor Pharmaceuticals、 Glenmark Pharmaceuticals、 Bristol Myers Squibb、 OriFarm、 Kohl Medical、 Paranova、 Torrent Pharmaceuticals、 Arcutis Biotherapeutics、 MSN Laboratories、 Viatris、 CSPC Ouyi Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PDE-4 Inhibitors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PDE-4 Inhibitors, with price, sales quantity, revenue, and global market share of PDE-4 Inhibitors from 2020 to 2025.
Chapter 3, the PDE-4 Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PDE-4 Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment PDE-4 Inhibitors the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the PDE-4 Inhibitors sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and PDE-4 Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PDE-4 Inhibitors.
Chapter 14 and 15, to describe PDE-4 Inhibitors sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PDE-4 Inhibitors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2961824/pde-4-inhibitors
According to our (Global Info Research) latest study, the global PDE-4 Inhibitors market size was valued at US$ 5292 million in 2024 and is forecast to a readjusted size of USD 7092 million by 2031 with a CAGR of 4.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
PDE-4 inhibitors are primarily used in the treatment of inflammatory and immune-mediated diseases, such as asthma, chronic obstructive pulmonary disease (COPD), psoriasis, and rheumatoid arthritis. Their development and production rely heavily on high-purity active pharmaceutical ingredients (APIs), such as apremilast and roflumilast, with upstream raw materials mainly supplied by fine chemical manufacturers and specialized API producers from Europe, the US, and India. The manufacturing process also requires excipients such as lactose, microcrystalline cellulose, hydroxypropyl methylcellulose, and magnesium stearate to ensure drug stability and bioavailability.
Downstream customers are concentrated among pharmaceutical companies, hospitals, specialty clinics, and retail pharmacies, spanning from prescription-driven markets in developed countries to public healthcare systems in emerging economies. Since PDE-4 inhibitors are often prescribed for long-term use to maintain therapeutic benefits, demand is characterized by large patient populations and extended treatment cycles, placing high requirements on manufacturers’ supply reliability. Moreover, with the ongoing expansion of therapeutic indications, several companies are actively promoting PDE-4 inhibitors in dermatology and rheumatology, providing new drivers for diversified market growth.
In 2024, the global average price of PDE-4 inhibitors is approximately USD 25.4 per unit (with "unit" referring to one oral tablet or one injectable), with total sales reaching about 202 million units.
This report is a detailed and comprehensive analysis for global PDE-4 Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
PDE-4 Inhibitors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Apremilast、 Crisaborole、 Roflumilast、 Others
Market segment by Application: Hospital、 Clinic、 Others
Major players covered: Amgen、 Pfizer、 AstraZeneca、 Anacor Pharmaceuticals、 Glenmark Pharmaceuticals、 Bristol Myers Squibb、 OriFarm、 Kohl Medical、 Paranova、 Torrent Pharmaceuticals、 Arcutis Biotherapeutics、 MSN Laboratories、 Viatris、 CSPC Ouyi Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PDE-4 Inhibitors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PDE-4 Inhibitors, with price, sales quantity, revenue, and global market share of PDE-4 Inhibitors from 2020 to 2025.
Chapter 3, the PDE-4 Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PDE-4 Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment PDE-4 Inhibitors the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the PDE-4 Inhibitors sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and PDE-4 Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PDE-4 Inhibitors.
Chapter 14 and 15, to describe PDE-4 Inhibitors sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PDE-4 Inhibitors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
